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There is a high demand for the synthesis of chiral amines as  building blocks for a large number of industrially 
valuable compounds. Transaminases (TAm) offer an enzymatic route for the synthesis of chiral amines that 
avoids complex chemical synthesis [1]. However, their catalytic efficiency towards bulky ketone substrates is 
greatly limited by steric hinderance [2]. This poster highlights a rational design strategy of combining in silico 
and in vitro methods to engineer the transaminase enzyme with a minimal number of mutations, achieving high 
catalytic activity and high enantioselectivity. The wildtype TAm showed no detectable activity towards the ketone 
2-acetylbiphenyl but upon introduction of two mutations detectable enzyme activity was observed. The reaction 
rate was improved a further 1716-fold with the rationally designed variant, that contained a further 5 mutations, 
producing the corresponding enantiomeric pure (S)-amine (enantiomeric excess (ee) value of >99%)[3].  
In addition, screening of in silico designed  (R)-TAm mutant panels in resolution mode offered an attractive and 
efficient route for the preparation of problematic (S)-amines. A mutant was identified from the panels that gave 
complete resolution of the racemic amine (high substrate loading) to leave the desired enantiomer at a low 
enzyme loading fit for process development towards an economically viable scale up process. 
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